Oxford Eye Hospital

Oxford OX39DU

2 studies enrolling now · 8 studies all time

What they study most

Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Telangiectasia Type 2 (MacTel), Retinitis Pigmentosa, STGD1, Stargardt, Stargardt Disease, Stargardt's Disease, X-Linked Retinitis Pigmentosa

Studies at this site

• An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene — Recruiting now
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP — Running, not enrolling
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Completed
• Study of Serine Supplementation to Protect Vision in MacTel — Starting soon
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment — Completed
• Safety and Tolerability of hRPC in Retinitis Pigmentosa — Status unconfirmed
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed